Inhibition of the Na,K-ATPase by the antiarrhythmic drug, Bretylium.
Gatto
Craig
C
Department of Biological Sciences, Illinois State University, Normal 61790-4120, USA. cgatto@ilstu.edu
Barkulis
C Theodore
CT
Schneider
William R
WR
Holden
Jeremy P
JP
Arnett
Krista L
KL
Milanick
Mark A
MA
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001950:Bretylium Tosylate / Q000494:pharmacology*; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology; D006321:Heart / Q000187:drug effects / Q000502:physiology; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D000889:Anti-Arrhythmia Agents; D001950:Bretylium Tosylate; D000254:Sodium-Potassium-Exchanging ATPase